The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Dr. Bazhenova on Potential Impact of Immunotherapy in Non-Driver NSCLC

Lyudmila A. Bazhenova, MD
Published Online: Sep 01,2017


Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses what potential impact immunotherapy agents could have on outcomes for patients with non-driver non–small cell lung cancer.


Clinical Articles

Dr. Bazhenova on Potential Impact of Immunotherapy in Non-Driver NSCLC
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.